Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1553 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
Input Field |
Entered |
SERIAL NUMBER | 88276835 |
---|---|
LAW OFFICE ASSIGNED | LAW OFFICE 114 |
EXTENSION OF USE | YES |
MARK SECTION | |
MARK | http://tmng-al.gov.uspto.report/resting2/api/img/88276835/large |
LITERAL ELEMENT | PLATO |
STANDARD CHARACTERS | YES |
USPTO-GENERATED IMAGE | YES |
MARK STATEMENT | The mark consists of standard characters, without claim to any particular font style, size or color. |
OWNER SECTION (current) | |
NAME | AVROBIO, Inc. |
INTERNAL ADDRESS | Building 300, Suite 201 |
STREET | One Kendall Square |
CITY | Cambridge |
STATE | Massachusetts |
ZIP/POSTAL CODE | 02139 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
OWNER SECTION (proposed) | |
NAME | AVROBIO, Inc. |
INTERNAL ADDRESS | Building 300, Suite 201 |
STREET | One Kendall Square |
CITY | Cambridge |
STATE | Massachusetts |
ZIP/POSTAL CODE | 02139 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
XXXX | |
ATTORNEY INFORMATION (current) | |
NAME | Michael J. Belliveau |
ATTORNEY BAR MEMBERSHIP NUMBER | NOT SPECIFIED |
YEAR OF ADMISSION | NOT SPECIFIED |
U.S. STATE/ COMMONWEALTH/ TERRITORY | NOT SPECIFIED |
FIRM NAME | CLARK+ELBING LLP |
STREET | 101 FEDERAL STREET, 15TH FLOOR |
CITY | BOSTON |
STATE | Massachusetts |
POSTAL CODE | 02110 |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
PHONE | 617-428-0200 |
FAX | 6174287045 |
cedocket@clarkelbing.com | |
DOCKET/REFERENCE NUMBER | 51182-T02001 |
ATTORNEY INFORMATION (proposed) | |
NAME | Michael J. Belliveau |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | CLARK+ELBING LLP |
STREET | 101 FEDERAL STREET, 15TH FLOOR |
CITY | BOSTON |
STATE | Massachusetts |
POSTAL CODE | 02110 |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
PHONE | 617-428-0200 |
FAX | 6174287045 |
cedocket@clarkelbing.com | |
DOCKET/REFERENCE NUMBER | 51182-T02001 |
OTHER APPOINTED ATTORNEY | Paul T. Clark, Karen L. Elbing, James D. DeCamp, Susan M. Michaud, J. Cooper McDonald, Richard Todd Armstrong, Jeffrey J. Ellison, Jan N. Tittel, Andrew R. Germain, Thomas J. Takara, Adil Zhugralin |
CORRESPONDENCE INFORMATION (current) | |
NAME | MICHAEL J. BELLIVEAU |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | cedocket@clarkelbing.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | NOT PROVIDED |
DOCKET/REFERENCE NUMBER | 51182-T02001 |
CORRESPONDENCE INFORMATION (proposed) | |
NAME | Michael J. Belliveau |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | cedocket@clarkelbing.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | NOT PROVIDED |
DOCKET/REFERENCE NUMBER | 51182-T02001 |
GOODS AND/OR SERVICES SECTION | |
INTERNATIONAL CLASS | 005 |
CURRENT IDENTIFICATION | Pharmaceuticals for treatment of rare and other diseases, namely, autoimmune diseases, diseases of the central nervous system, and oncological diseases |
GOODS OR SERVICES | DELETE ALL ITU GOODS/SERVICES IN THIS CLASS OR PROCESS ACCORDING TO REQUEST TO DIVIDE |
INTERNATIONAL CLASS | 042 |
CURRENT IDENTIFICATION | Platform as a service (PAAS) featuring gene therapy development platforms for treatments for rare and other diseases |
GOODS OR SERVICES | KEEP ALL LISTED |
FIRST USE ANYWHERE DATE | 03/00/2020 |
FIRST USE IN COMMERCE DATE | 03/00/2020 |
SPECIMEN FILE NAME(S) | |
ORIGINAL PDF FILE | SPN1-382423194-20200330111050057681_._PLATO.pdf |
CONVERTED PDF FILE(S) (2 pages) |
\\TICRS\EXPORT18\IMAGEOUT18\889\775\88977547\LM2Copy\88276835\1\SOU14\SOU2.JPG |
\\TICRS\EXPORT18\IMAGEOUT18\889\775\88977547\LM2Copy\88276835\1\SOU14\SOU3.JPG | |
SPECIMEN DESCRIPTION | Image of applicant website showing platform as a service (PAAS) featuring gene therapy development platforms for treatments for rare and other diseases |
REQUEST TO DIVIDE | YES |
GOOD(S)/SERVICE(S) IN USE | Platform as a service (PAAS) featuring gene therapy development platforms for treatments for rare and other diseases |
GOOD(S)/SERVICES INTENT TO USE | Pharmaceuticals for treatment of rare and other diseases, namely, autoimmune diseases, diseases of the central nervous system, and oncological diseases |
PAYMENT SECTION | |
NUMBER OF CLASSES IN USE | 1 |
SUBTOTAL AMOUNT [ALLEGATION OF USE FEE] | 100 |
REQUEST TO DIVIDE FEE | 100 |
TOTAL AMOUNT | 200 |
SIGNATURE SECTION | |
DECLARATION SIGNATURE | /Jan N. Tittel/ |
SIGNATORY'S NAME | Jan N. Tittel |
SIGNATORY'S POSITION | Attorney of record, Massachusetts bar member |
DATE SIGNED | 03/31/2020 |
SIGNATORY'S PHONE NUMBER | 6174280200 |
SUBMISSION SIGNATURE | /Jan N. Tittel/ |
SIGNATORY'S NAME | Jan N. Tittel |
SIGNATORY'S POSITION | Attorney of record, Massachusetts bar member |
DATE SIGNED | 03/31/2020 |
SIGNATORY'S PHONE NUMBER | 6174280200 |
AUTHORIZED SIGNATORY | YES |
FILING INFORMATION | |
SUBMIT DATE | Tue Mar 31 10:38:39 ET 2020 |
TEAS STAMP | USPTO/SOU-XX.XXX.X.XXX-20 200331103839135414-882768 35-7109acc8bfb91af4c3029f 4613a525b65b580f5143a18a0 c71a3840fb329e6e8853-DA-3 8383862-20200331103349202 373 |
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1553 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
The signatory believes that the applicant is the owner of the mark sought to be registered. For a trademark or service mark application, the mark is in use in commerce on or in connection with all the goods/services in the application or notice of allowance, or as subsequently modified. For a collective trademark, collective service mark, collective membership mark application, the applicant is exercising legitimate control over the use of the mark in commerce by members on or in connection with all the goods/services/collective membership organization in the application or notice of allowance, or as subsequently modified. For a certification mark application, the applicant is exercising legitimate control over the use of the mark in commerce by authorized users on or in connection with the all goods/services in the application or notice of allowance, or as subsequently modified, and the applicant is not engaged in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that meet the certification standards of the applicant. |
|
The specimen(s) shows the mark as used on or in connection with the goods/services/collective membership organization in commerce. | |
To the best of the signatory's knowledge and belief, no other persons, except, if applicable, authorized users, members, and/or concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive. | |
To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support. | |
The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true. |